Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses.

The steroid hormone estradiol (E2) elicits a spectrum of systemic and uterotropic responses in vivo. For example, E2 treatment of ovariectomized adult and sexually immature rodents leads to uterine leukocytic infiltration, cell proliferation, and organ growth. E2-regulated growth is also associated with a variety of normal and pathological phenotypes. Historically, the uterine growth response has been used as the key model to understand the molecular and biochemical mechanisms underlying E2-dependent growth. In this study, genome exclusion mapping identified two quantitative trait loci (QTL) in the mouse, Est2 and Est3 on chromosomes 5 and 11, respectively, that control the phenotypic variation in uterine wet weight. Both QTL are linked to a variety of E2-regulated genes, suggesting that they may represent loci within conserved gene complexes that play fundamental roles in mediating the effects of E2. Interaction and multiple trait analyses using the uterine leukocyte response and wet weight suggest that Est4, a QTL on chromosome 10, may encode an interacting factor that influences the quantitative variation in both responses. Our results show that E2-dependent responses can be genetically controlled and that a genetic basis may underlie the variation observed in many E2-dependent phenotypes.

[1]  R. Doerge,et al.  Autoimmune orchitis, epididymitis, and vasitis are immunogenetically distinct lesions. , 1998, The American journal of pathology.

[2]  Carolyn L. Smith,et al.  Cross-talk between peptide growth factor and estrogen receptor signaling pathways. , 1998, Biology of reproduction.

[3]  B. Pentecost Expression and estrogen regulation of the HEM45 mRNA in human tumor lines and in the rat uterus , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  L. Bennett,et al.  Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice , 1998, Oncogene.

[5]  E. Keller,et al.  Immunologic aspects of osteoporosis. , 1997, Developmental and comparative immunology.

[6]  R. Bigsby,et al.  A novel estrogen-enhanced transcript identified in the rat uterus by differential display. , 1997, Endocrinology.

[7]  Rebecca W. Doerge,et al.  Statistical issues in the search for genes affecting quantitative traits in experimental populations , 1997 .

[8]  Chun-Fang Xu,et al.  Complex Regulation of the BRCA1 Gene* , 1997, The Journal of Biological Chemistry.

[9]  Cory,et al.  Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes. , 1997, The American journal of pathology.

[10]  L. Bennett,et al.  Brca1 is expressed independently of hormonal stimulation in the mouse ovary. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[11]  A. Futreal,et al.  BRCA1 expression is not directly responsive to estrogen , 1997, Oncogene.

[12]  F. Bazer,et al.  Spatial and temporal analyses of integrin and Muc-1 expression in porcine uterine epithelium and trophectoderm in vivo. , 1996, Biology of reproduction.

[13]  D. Pfaff,et al.  Estrogen and thyroid hormone interaction on regulation of gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Bowcock,et al.  BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. , 1996, Oncogene.

[15]  B. Katzenellenbogen Estrogen receptors: bioactivities and interactions with cell signaling pathways. , 1996, Biology of reproduction.

[16]  C. Hegele-hartung,et al.  Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  H. Nguyen,et al.  Hormone-dependent regulation of BRCA1 in human breast cancer cells. , 1995, Cancer research.

[18]  P. Deininger,et al.  Identification of a New Subclass of Alu DNA Repeats Which Can Function as Estrogen Receptor-dependent Transcriptional Enhancers (*) , 1995, The Journal of Biological Chemistry.

[19]  Z B Zeng,et al.  Multiple trait analysis of genetic mapping for quantitative trait loci. , 1995, Genetics.

[20]  R. Doerge,et al.  Empirical threshold values for quantitative trait mapping. , 1994, Genetics.

[21]  S. Mani,et al.  Actions of ovarian steroid hormones , 1994 .

[22]  R T Turner,et al.  Skeletal effects of estrogen. , 1994, Endocrine reviews.

[23]  P. Tuohimaa,et al.  Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  J. Todd,et al.  Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Gorski,et al.  Estrogen receptors, estradiol, and diethylstilbestrol in early development: the mouse as a model for the study of estrogen receptors and estrogen sensitivity in embryonic development of male and female reproductive tracts. , 1993, Endocrine reviews.

[26]  P. Sehgal,et al.  Secretion and hormonal regulation of interleukin-6 production by mouse uterine stromal and polarized epithelial cells cultured in vitro. , 1992, Endocrinology.

[27]  E S Lander,et al.  A genetic map of the mouse suitable for typing intraspecific crosses. , 1992, Genetics.

[28]  Soumitra Ghosh,et al.  Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.

[29]  J. Love,et al.  Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. , 1990, Nucleic acids research.

[30]  R. Arceci,et al.  Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  U. Santhanam,et al.  Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. , 1989, Journal of immunology.

[32]  M. Daly,et al.  MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. , 1987, Genomics.

[33]  B. Komm,et al.  Estrogen Regulation of α1(I)-Procollagen Messenger Ribonucleic Acid in the Rat Uterus* , 1987 .

[34]  S. Ansar Ahmed,et al.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. , 1985, The American journal of pathology.

[35]  S. Ichida,et al.  Increase of serotonin receptors in rat uterus induced by estradiol. , 1983, The Journal of biological chemistry.

[36]  D. Ong,et al.  Variable expression of cellular retinol- and cellular retinoic acid-binding proteins in the rat uterus and ovary during the estrous cycle. , 1997, Biology of reproduction.

[37]  Yager Jd,et al.  Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .

[38]  M. Thie,et al.  Differential expression and localization of integrins and CD44 in the membrane domains of human uterine epithelial cells during the menstrual cycle. , 1995, Acta anatomica.

[39]  J. Sudweeks Locus conteolling Bordetella perussis-induced histamine sensitization(Bphs), an autoimmune disease-susceptibility gene, chromosome 6 , 1993 .

[40]  S. Lincoln Constructing genetic maps with MAPMAKER/EXP 3.0. , 1992 .

[41]  E. Lander,et al.  Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. , 1989, Genetics.